These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36742213)

  • 1. Anticoagulant Use During Extracorporeal Membrane Oxygenation Using Heparin and Direct Thrombin Inhibitors in COVID-19 and ARDS Patients.
    Stammers AH; Tesdahl EA; Barletti S; Mongero L; Patel K; Mosca M; Sestokas A; Firstenberg MS; Jacobs JP
    J Extra Corpor Technol; 2022 Sep; 54(3):223-234. PubMed ID: 36742213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Thrombin Inhibition in Extracorporeal Membrane Oxygenation.
    Geli J; Capoccia M; Maybauer DM; Maybauer MO
    Int J Artif Organs; 2022 Jul; 45(7):652-655. PubMed ID: 35411823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes With Direct and Indirect Thrombin Inhibition During Extracorporeal Membrane Oxygenation for COVID-19.
    Saeed O; Farooq M; Kuntzman M; Patel SR; Stein LH; Cavarocchi N; Silvestry S; Reyes Gil M; Billett HH; Jorde UP; Goldstein DJ
    ASAIO J; 2022 Dec; 68(12):1428-1433. PubMed ID: 35671537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19.
    Seelhammer TG; Rowse P; Yalamuri S
    J Cardiothorac Vasc Anesth; 2021 Apr; 35(4):1149-1153. PubMed ID: 32660924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study.
    Mayerhöfer T; Joannidis M; Peer A; Perschinka F; Fries D; Mair P; Gasteiger L; Bachler M; Kilo J; Herkner H; Schwameis M; Schellongowski P; Nagler B; Kornfehl A; Staudinger T; Buchtele N
    Thromb Res; 2024 Apr; 236():161-166. PubMed ID: 38452448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation.
    Berei TJ; Lillyblad MP; Wilson KJ; Garberich RF; Hryniewicz KM
    ASAIO J; 2018; 64(5):623-629. PubMed ID: 29076942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation strategies in COVID-19 infected patients receiving ECMO support.
    Diaz D; Martinez J; Bushman G; Wolowich WR
    J Extra Corpor Technol; 2023 Sep; 55(3):121-129. PubMed ID: 37682210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in outcomes with extracorporeal membrane oxygenation in the era of coronavirus: A multicenter cohort evaluation.
    Stammers AH; Tesdahl EA; Sestokas AK; Mongero LB; Patel K; Barletti S; Firstenberg MS; St Louis JD; Jain A; Bailey C; Jacobs JP; Weinstein S
    Perfusion; 2023 Oct; 38(7):1501-1510. PubMed ID: 35943298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO).
    Kaushik S; Derespina KR; Chandhoke S; Shah DD; Cohen T; Shlomovich M; Medar SS; Peek GJ
    Perfusion; 2023 Jan; 38(1):58-65. PubMed ID: 34318718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Wholesale Drug Acquisition and Laboratory Assessment Costs Between Heparin Compared With Bivalirudin-Based Systemic Anticoagulation Strategies in Adult Extracorporeal Membrane Oxygenation.
    Seelhammer TG; Brokmeier HM; Hamzah M; Wieruszewski PM
    Crit Care Med; 2023 May; 51(5):e115-e121. PubMed ID: 36853326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis.
    M'Pembele R; Roth S; Metzger A; Nucaro A; Stroda A; Polzin A; Hollmann MW; Lurati Buse G; Huhn R
    Thromb J; 2022 Jul; 20(1):42. PubMed ID: 35902857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation Management during Extracorporeal Membrane Oxygenation-A Mini-Review.
    Burša F; Sklienka P; Frelich M; Jor O; Ekrtová T; Máca J
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36556985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
    Krueger K; Schmutz A; Zieger B; Kalbhenn J
    Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
    Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
    J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study.
    Tong Y; Rouzhahong J; Zhou W; Wang R; Wang Y; Ren Y; Guo J; Li Y; Wang Z; Song Y
    Int J Artif Organs; 2023 Mar; 46(3):162-170. PubMed ID: 36600413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of anticoagulation for children supported by extracorporeal membrane oxygenation in the United States: A Pediatric Hospital Information System database study.
    Nellis ME; An A; Mahmood H; Prishtina F; Hena Z; Karam O
    Perfusion; 2024 Apr; 39(3):536-542. PubMed ID: 36606508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study.
    Fisser C; Winkler M; Malfertheiner MV; Philipp A; Foltan M; Lunz D; Zeman F; Maier LS; Lubnow M; Müller T
    Crit Care; 2021 Apr; 25(1):160. PubMed ID: 33910609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris.
    Schmidt M; Langouet E; Hajage D; James SA; Chommeloux J; Bréchot N; Barhoum P; Lefèvre L; Troger A; de Chambrun MP; Hékimian G; Luyt CE; Dres M; Constantin JM; Fartoukh M; Leprince P; Lebreton G; Combes A;
    Crit Care; 2021 Oct; 25(1):355. PubMed ID: 34627350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of argatroban in patients receiving extracorporeal membrane oxygenation support: a case-control study].
    Zhang Z; Tang X; Wang R; Li X; Li Y; Tong Z; Sun B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1305-1310. PubMed ID: 36567588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Bivalirudin as the Primary Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation for SARS-CoV-2-Associated Acute Respiratory Failure.
    Bissell BD; Gabbard T; Sheridan EA; Baz MA; Davis GA; Ather A
    Ann Pharmacother; 2022 Apr; 56(4):387-392. PubMed ID: 34323121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.